Researchers evaluated protection conferred by a single COVID-19 mRNA vaccine dose vs a 2-dose series in the setting of high preexisting SARS-CoV-2 immunity.

Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the ...

A year after the first samRNA vaccine approval, experts say others are likely to face scientific and regulatory hurdles.

COVID-19 vaccination is associated with a reduced risk for most CV events, but with slightly increased risks for extrasystoles and transient ischemic attack, as well as myocarditis and pericarditis ...

COVID-19 2024–2025 vaccines are recommended for everyone aged 6 months and older, with vaccines targeting the JN.1 and KP.2 strains of SARS-CoV-2.

The first day of flu and COVID shots set a single-day record, with 82,000 shots administered through B.C. pharmacies ...

Moderna is focusing on respiratory vaccines to sustain revenue streams amid COVID-19 declines. See more on MRNA stock and its ...

The UK Government has recommended offering a COVID-19 booster vaccination in autumn, 2024, to individuals at high risk of ...

WA Premier Roger Cook has called on Port Hedland councillor Adrian McRae to quit after quoting a Nazi and attacking Western ...

Nearly 10.4M New Yorkers, or 53%, got the flu shot last year. Only about 12% got the COVID shot. Here's why, how officials ...

We recently published a list of 10 Best Depressed Stocks To Buy Heading into 2025. In this article, we are going to take a ...

The late-stage trial will recruit about 25,000 people around the world to test the new vaccine from Moderna.View on euronews ...